SARAH KEIM: Open Payments
NPI 1285490847 · CHESTERFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$34,417 in 77 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $169 · 2025 $34,417
Speaker / faculty: $26,400Travel & lodging: $6,712Food & beverage: $1,306
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 66 | $34,033 |
| GENZYME CORPORATION | 4 | $246 |
| Aimmune Therapeutics, Inc. | 4 | $84 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Janssen Biotech, Inc. | 1 | $20 |
| Celltrion USA Inc. | 1 | $14 |
Products named: BOTOX, DUPIXENT, ZENPEP, RINVOQ, SKYRIZI, ENTYVIO, TREMFYA, VEGZELMA.
Industry payments across MO — which companies pay providers there.
